REDITUX RA 500MG INJECTION

The active ingredient in Reditux RA 500 mg injection is rituximab. It is used to treat several diseases in adults. It can be used with or without other medications for the treatment of non-Hodgkin lymphoma, cancer affecting B-cells (white blood cells) and chronic In adults, it is indicated for treating moderate to severe rheumatoid (a disease in which the immune system attacks its body cells called leukapheresis) when combined with methotrexate. Also, granulomatosis polyangiitis and microscopic polyangiitis are used to treat inflammation of blood vessels in the lungs and kidneys of adults and children older than two years. It can also treat mild to moderate pemphigus (an autoimmune disease that causes painful blisters on the skin, lining, and nose of the mouth and throat).
The anti-CD20 monoclonal antibody class includes Reditux RA 500mg injection . This injection should not be taken if you have an allergy to rituximab, any other ingredients in this medication, a weakened immune system or a severe infection. Before starting the treatment, tell your doctor if you suffer from heart disease, heart failure or breathing issues. Speak to your doctor if you’ve ever had hepatitis B. The infection can reactivate in some cases, and it can sometimes be very severe. This injection is not recommended during pregnancy or breastfeeding.
Reditux RA 500 mg  injections can cause side effects such as blood infection, reduced red blood cell count, dizziness, and swelling of the face and body. Other common symptoms include diarrhoea, increased sweating and high blood pressure. If you are pregnant, use effective contraception during treatment and for 12 months following the last dose. This medication may cause severe infusion reactions during or within 24 hours after administration. Infusion reactions such as chest pain, headaches, breathing problems, vomiting, skin irritations, or swelling of the throat or skin should be reported to your doctor or healthcare professional.